Novartis Investigative Site

Joliette, Quebec J6E 6J2

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Chronic Heart Failure, Chronic Obstructive Pulmonary Disease

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed
• Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations — Completed